Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

SELF-ASSEMBLING BACTERIA CAN MAKE A BETTER DRUG FACTORY

SELF-ASSEMBLING BACTERIA CAN MAKE A BETTER DRUG FACTORY

Various strains of genetically engineered bacteria have been used as industrial workhorses for years. It’s a straightforward idea: you engineer a bacterium’s genome so that when it eats specific things, it exudes or excretes the exact product you want.

Engineered bacteria are making drug compounds, neutralizing toxic waste, and serving a range of other useful purposes.

Researchers at Rice University have streamlined the process of making the bacteria themselves, which has always added time and cost to bacteria-based projects.

The scientists chose a bug called Caulobacter crescentus because it can display a wide variety of proteins on its surface, making it a utility player for industry.

The Rice group tinkered with the bacterium’s genome so that it “self-assembles from the bottom up,” the scientists reported.

That means each bacterium grows from a single engineered cell without further intervention. Put the designer cells in a nutrient medium, set them aside, and come back a day later when the bacteria have reached about a centimeter in size, roughly a third of an inch.

The microbes were engineered to secrete a biopolymer matrix that gives their mass some form, and also are “tunable,” meaning their genomes can be engineered to carry out a wide range of functions.

Self-assembly can save time; it also can cut costs by dispensing with specialized equipment and lab technicians, making “biomanufacturing” available to a range of products and industries that might not have been able to adopt it yet.

The materials, which are shelf-stable for about three weeks, can repair themselves if damaged on the job, so they also last longer and require less human intervention.

In tests, the designer bugs performed as they were engineered to do, including, in one case, pulling cadmium from a water sample.

The new materials are likely to find uses as filters, aids in fermenting and homogenizing, and in making plastics, detergents, and even protein supplements for humans.

TRENDPOST: Biomanufacturing can be simpler, cleaner, and cheaper than using the usual array of machines and synthetic chemicals. As a result, it will claim a larger role in producing a range of products.

However, the same concerns about pollution remain. Not only is there the issue of noxious waste, but also of containing bugs that could mutate or cause unforeseen havoc if they escape into the wild.